View

The Study

Short sirolimus half‐life in pediatric renal transplant recipients on a calcineurin inhibitor‐free protocol

In simple terms

This study is like taking a snapshot of 13 kids who got a certain medicine after a kidney transplant. It tells us what happened to their medicine levels, but it doesn’t compare them to other kids or prove that the medicine caused any specific result.

36%

Analysis score

36/ 44

Maximum 44 for a cross-sectional study.

Where the score came from

Reporting0
Methodology14
Publication100
Statistical46
Study type (basis of the score)
Cross-Sectional Study
Level 4 - Case series
What’s the bottom line?

Doctors gave a drug called sirolimus to kids after kidney transplants and checked how long it stayed in their bodies. They found it leaves faster in kids than in adults, so they might need to take it more often.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Cross-Sectional & Case Series
Level 4
36

36 / 100

Quality score

Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.

Cannot establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

  1. 1Yes, this matters because if the drug leaves quickly, kids may need more frequent doses to stay protected from organ rejection.
  2. 2Sirolimus stayed in the body for about 10.8 hours at first and 12.1 hours later.
  3. 3The medicine level in the blood before the next dose showed well how much medicine the body got overall (r² = 0.84).
  4. 4The other medicine (mycophenolic acid) didn’t change how sirolimus worked (r² = 0.04).

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data

Publication

Journal

Pediatric Transplantation

Year

2004

Authors

A. Schachter, A. Schachter, K. Meyers, Leslie Spaneas, J. Palmer, M. Salmanullah, J. Baluarte, K. Brayman, W. Harmon

Open Access
68 citations
Analysis v5
Fit Body Science verdict — we translate health studies into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.